Skip to content

Effects of tDCS Combined With VR on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination

Effects of tDCS Combined With Virtual Reality on Anxious Ruminations in Healthy Subjects With a Vulnerability to Rumination

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03915041
Acronym
REVISTIM-XX
Enrollment
20
Registered
2019-04-16
Start date
2019-05-15
Completion date
2020-08-14
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rumination

Keywords

virtual reality, brain stimulation, tDCS, phenomenology

Brief summary

This study proposes: to evaluate 1) whether the combination of virtual reality (VR) and active tDCS provides better rumination attenuation than the combination of VR and tDCS placebo 2) the acceptability and experiential experience of combining these two well known medical devices.

Detailed description

Inclusion visit: * Confirmation of eligibility criteria * Written informed consent Visit 1 and 2 (or end of study visit) : Before first ruminations induction : * Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI), Inventory, Visual Analogic Scale (VAS), Ruminative Response Scale - Short Form (RRS-SF), Beck depression Inventory (BDI) * EEG recording Then Procedure for inducing ruminations using a pre-recorded voice listened to in an audio headset alternating statements promoting a positive, neutral and negative introspection and self-judgment attitude (the latter are heard at the end to initiate the rumination process) over 8 minutes Then * Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), * EEG recording * Pulse and blood pressure measurements Then immersion in a relaxing virtual environment for 20 minutes with active or sham placebo. • Cutaneous conductance measurement and eye-tracking during immersion At the end of immersion : * Completion of Brief State Rumination Inventory (BSRI), Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), IGroup presence questionnaire (IPQ) * Pulse and blood pressure measurements Then again procedure for inducing ruminations . At the end of ruminations induction : * Completion of Brief State Rumination Inventory (BSRI), State-Trait Anxiety (STAI), Inventory, Visual Analogic Scale (VAS), Beck depression Inventory (BDI), tolerance questionnaires * Debriefing

Interventions

Active Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)

DEVICEVR +sham brain stimulation

Sham Brain stimulation (tDCS) is applied during exposition to virtual reality (20 minutes)

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Without any particular ethnic and psychosocial criteria * Subject to ruminations (personality trait) documented by a RRS-SF score \>30 * Subjects with score to BDI scal \<14 assessed during first visit * Subjects without psychiatric or addictive disorders. * Subjects who do not meet all the diagnostic criteria for an anxiety disorder or characterized depressive episode.

Exclusion criteria

* contraindication to tDCS (neurosurgical history, intracranial device, skin problems) * current virtual reality intolerance * history of psychiatric or addictive disorders * Use of psychotropic drugs * Use of non psychotropic treatments significantly influencing mood or level of anxiety * pregnant or breast-feeding women * Neurological pathology, locomotor disability, or sensory (vestibular, visual, auditory ...)

Design outcomes

Primary

MeasureTime frameDescription
Change in anxious ruminations after anodal tDCS and virtual realitywithin 1 weekChange in anxious ruminations after anodal tDCS and virtual reality will be evaluated to compare the effects of tDCS associated with virtual reality versus virtual reality alone (+ tDCS placebo) to reduce ruminations. Evaluate with Brief State Ruminative Inventory (BSRI). It is a scale with 8 items. Each item is VAS with a score ranging between 0 and 100. The total score is sum of each item score (Total /800)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 15, 2026